Education
About Us
Working with TipRanks
Follow Us
Hua Medicine (HK:2552)
:2552
Total Valuation
Hua Medicine has a market cap or net worth of HK$1.93B. The enterprise value is HK$1.10B.
Market CapHK$1.93B
Enterprise ValueHK$1.10B
Share Statistics
Hua Medicine has 1,055,588,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,055,588,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Hua Medicine’s return on equity (ROE) is 1.85 and return on invested capital (ROIC) is -26.87%.
Return on Equity (ROE)1.85
Return on Assets (ROA)-0.16
Return on Invested Capital (ROIC)-26.87%
Return on Capital Employed (ROCE)-0.29
Revenue Per Employee1.52M
Profits Per Employee-1.49M
Employee Count168
Asset Turnover0.17
Inventory Turnover1.04
Valuation Ratios
The current PE Ratio of Hua Medicine is -5.38. Hua Medicine’s PEG ratio is -2.01.
PE Ratio-5.38
PS Ratio0.00
PB Ratio-14.30
Price to Fair Value-9.93
Price to FCF-4.64
Price to Operating Cash Flow-4.63
PEG Ratio-2.01
Income Statement
In the last 12 months, Hua Medicine had revenue of 255.89M and earned -250.14M in profits. Earnings per share was -0.25.
Revenue255.89M
Gross Profit124.72M
Operating Income-360.31M
Pretax Income-250.14M
Net Income-250.14M
EBITDA-345.36M
Earnings Per Share (EPS)-0.25
Cash Flow
In the last 12 months, operating cash flow was -417.97M and capital expenditures 0.00, giving a free cash flow of -417.97M billion.
Operating Cash Flow-417.97M
Free Cash Flow-417.97M
Free Cash Flow per Share-0.40
Dividends & Yields
Hua Medicine pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.91
52-Week Price Change31.29%
50-Day Moving Average2.19
200-Day Moving Average1.62
Relative Strength Index (RSI)47.48
Average Volume (3m)2.58M
Important Dates
Hua Medicine upcoming earnings date is Aug 21, 2025, TBA Not Confirmed.
Last Earnings DateMar 27, 2025
Next Earnings DateAug 21, 2025
Ex-Dividend Date―
Financial Position
Hua Medicine as a current ratio of 4.05, with Debt / Equity ratio of -221.59%
Current Ratio4.05
Quick Ratio3.66
Debt to Market Cap0.18
Net Debt to EBITDA2.43
Interest Coverage Ratio-40.96
Taxes
In the past 12 months, Hua Medicine has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Hua Medicine EV to EBITDA ratio is -1.47, with an EV/FCF ratio of -1.20.
EV to Sales1.98
EV to EBITDA-1.47
EV to Free Cash Flow-1.20
EV to Operating Cash Flow-1.21
Balance Sheet
Hua Medicine has HK$1.14B in cash and marketable securities with ¥300.18M in debt, giving a net cash position of -HK$839.57M billion.
Cash & Marketable SecuritiesHK$1.14B
Total Debt¥300.18M
Net Cash-HK$839.57M
Net Cash Per Share-HK$0.80
Tangible Book Value Per Share-HK$0.16
Margins
Gross margin is 48.74%, with operating margin of -137.81%, and net profit margin of -97.75%.
Gross Margin48.74%
Operating Margin-137.81%
Pretax Margin-97.75%
Net Profit Margin-97.75%
EBITDA Margin-134.96%
EBIT Margin-140.80%
Analyst Forecast
The average price target for Hua Medicine is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast221.43%
EPS Growth Forecast-16.04%